Bawei Aiguning Granules For Lung Cancer Bone Metastases: A Randomized, Double-blind, Placebo-Controlled Trial Protocol With A Representative Case
Journal of Visualized Experiments · 2026
DOI: 10.3791/69906 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2026. Written by Peng Zhao and 14 co-authors. Institution: Longhua Hospital, Shanghai University of Traditional Chinese Medicine; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Educati…. Major MEDLINE topics: Bone Neoplasms, Lung Neoplasms, Drugs, Chinese Herbal. 47 references.
Abstract (original language)
Bone metastases (BM) frequently lead to skeletal-related events (SREs) and significant pain in lung cancer patients, requiring more effective supportive management strategies. We designed a prospective, multicenter, randomized, double-blind, placebo-controlled trial to evaluate Bawei Aiguning Granules (BWAGN) in combination with standard bone-targeted therapy. A total of 156 patients will be randomized across six centers. The primary endpoint is the 1-year incidence of SREs. Secondary endpoints include time to first SRE, pain assessment, quality of life, survival, Traditional Chinese Medicine symptom score, and bone turnover markers. Safety will be assessed according to Common Terminology Criteria for Adverse Events v5.0. Alongside the trial protocol, this manuscript presents currently available descriptive observations from a representative participant. During follow-up, no SREs were documented, and serial Electron Computed Tomography (ECT) examinations showed no obvious new imaging abnormalities suggestive of bone progression or SRE-related change. Functional status, symptom burden, and tumor markers showed favorable changes over time, while routine safety assessments remained generally stable, with no adverse events or serious adverse events recorded. These observations are descriptive only and should be interpreted with caution. Definitive conclusions regarding efficacy and safety will require completion of the protocol-defined follow-up and formal analysis of the full study cohort.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Longhua Hospital, Shanghai University of Traditional Chinese Medicine; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education.
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine.
- Longhua Hospital, Shanghai University of Traditional Chinese Medicine; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education; yjwang8888@126.com.
- Longhua Hospital, Shanghai University of Traditional Chinese Medicine; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education; sxy13407137854@163.com.
- Longhua Hospital, Shanghai University of Traditional Chinese Medicine; Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education; yanpingyangks@163.com.
Cite
APA
Zhao, P., Hong, Y., Chang, J., Guo, S., Yan, B., Zhou, C., Wang, X., Zhao, F., Tong, J., Zhang, X., Jiao, L., Gong, Y., Wang, Y., Sun, X., & Yang, Y. (2026). Bawei Aiguning Granules For Lung Cancer Bone Metastases: A Randomized, Double-blind, Placebo-Controlled Trial Protocol With A Representative Case. Journal of Visualized Experiments. https://doi.org/10.3791/69906
Vancouver
Zhao P, Hong Y, Chang J, Guo S, Yan B, Zhou C, et al. Bawei Aiguning Granules For Lung Cancer Bone Metastases: A Randomized, Double-blind, Placebo-Controlled Trial Protocol With A Representative Case. Journal of Visualized Experiments. 2026. doi:10.3791/69906
BibTeX
@article{Zhao2026,
author = {Zhao, Peng and Hong, Yuping and Chang, Junli and Guo, Suxia and Yan, Binghan and Zhou, Chujie and Wang, Xiaobo and Zhao, Fulai and Tong, Junjie and Zhang, Xinyu and Jiao, Lijing and Gong, Yabin and Wang, Yongjun and Sun, Xingyuan and Yang, Yanping},
title = {Bawei Aiguning Granules For Lung Cancer Bone Metastases: A Randomized, Double-blind, Placebo-Controlled Trial Protocol With A Representative Case},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/69906}
}
EUVIMED